Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Cell Culture
SUBMITTER: Chaoshuang Xia
LAB HEAD: Catherine E. Costello
PROVIDER: PXD047910 | Pride | 2024-05-22
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
090921_HCA_N_IgG.raw | Raw | |||
090921_HCA_N_IgG.xlsx | Xlsx | |||
20220701_HCA_mRNA_VK2_IgG.raw | Raw | |||
20220701_HCA_mRNA_VK2_IgG.xlsx | Xlsx | |||
20230802_HCA_N_IgG_18O_Deglycosylated.raw | Raw |
Items per page: 5 1 - 5 of 9 |
Nador Ellena E Xia Chaoshuang C Santangelo Philip J PJ Whaley Kevin J KJ Costello Catherine E CE Anderson Deborah J DJ
Antibodies (Basel, Switzerland) 20240306 1
IgG Fc <i>N</i>-glycosylation is necessary for effector functions and is an important component of quality control. The choice of antibody manufacturing platform has the potential to significantly influence the Fc glycans of an antibody and consequently alter their activity and clinical profile. The Human Contraception Antibody (HCA) is an IgG1 antisperm monoclonal antibody (mAb) currently in clinical development as a novel, non-hormonal contraceptive. Part of its development is selecting a suit ...[more]